Skip to main content
Log in

Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Wenninger S, Montagnese F, Schoser B (2018) Core clinical phenotypes in myotonic dystrophies. Front Neurol 9:303. https://doi.org/10.3389/fneur.2018.00303

    Article  PubMed  PubMed Central  Google Scholar 

  2. Heatwole C, Johnson N, Bode R, Dekdebrun J, Dilek N, Hilbert JE, Luebbe E, Martens W, McDermott MP, Quinn C, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT (2015) Patient-reported impact of symptoms in myotonic dystrophy type 2 (PRISM-2). Neurology 85(24):2136–2146. https://doi.org/10.1212/WNL.0000000000002225

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R (2012) Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 79(4):348–357. https://doi.org/10.1212/WNL.0b013e318260cbe6

    Article  PubMed  PubMed Central  Google Scholar 

  4. Suokas KI, Haanpää M, Kautiainen H, Udd B, Hietaharju AJ (2012) Pain in patients with myotonic dystrophy type 2: a postal survey in Finland. Muscle Nerve 45(1):70–74. https://doi.org/10.1002/mus.22249

    Article  PubMed  Google Scholar 

  5. Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W (2018) Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev 3:CD012182. https://doi.org/10.1002/14651858.CD012182.pub2

    Article  Google Scholar 

  6. Sexton M, Cuttler C, Finnell JS, Mischley LK (2016) A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy. Cannabis Cannabinoid Res 1(1):131–138. https://doi.org/10.1089/can.2016.0007

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bagüés A, Martín MI, Sánchez-Robles EM (2014) Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain. Eur J Pharmacol 745:69–75. https://doi.org/10.1016/j.ejphar.2014.10.016

    Article  CAS  PubMed  Google Scholar 

  8. Cavuoto P, McAinch AJ, Hatzinikolas G, Janovská A, Game P, Wittert GA (2007) The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Biochem Biophys Res Commun 364(1):105–10

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We like to thank all members of the Myotonic Dystrophies Foundation MDF, San Francisco, USA, and Diagnosegruppe Myotone Dystrophien, Deutsche Gesellschaft für Muskelkranke, Freiburg Germany for all the enthusiasm and ongoing support for our project, and Nexien Biopharma, Inc. for their support of cannabinoid-based, FDA compliant, solutions to help alleviate the symptoms of DM.

Funding

There was no funding for this survey.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benedikt Schoser.

Ethics declarations

Conflicts of interest

FM, MW, AK, KS, SW have no conflicts of interest. BS is a scientific advisor of Nexien BioPharma, Inc.

Ethical standard

This study followed the tenets of the Declaration of Helsinki. As this survey was a patient organization (MW, AK) driven survey, done anonymously and blinded, no formal IRB approval was submitted.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Montagnese, F., White, M., Klein, A. et al. Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey. J Neurol 266, 530–532 (2019). https://doi.org/10.1007/s00415-018-9159-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-018-9159-2

Navigation